TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. SPY
6. ACN
7. NVDA
8. PRIM
9. META
10. PFE

Go back to TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Pfizer Inc. (NYSE: PFE) Delayed: 24.88 -0.2 (0.8%)
Previous Close $25.08    52 Week High $37.39 
Open $24.99    52 Week Low $28.25 
Day High $25.24    P/E 15.08 
Day Low $24.78    EPS $1.65 
Volume 25,179,413